These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18325103)

  • 1. CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer.
    Larson PS; Schlechter BL; King CL; Yang Q; Glass CN; Mack C; Pistey R; de Las Morenas A; Rosenberg CL
    BMC Cancer; 2008 Mar; 8():68. PubMed ID: 18325103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
    Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
    Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.
    Rodriguez BA; Weng YI; Liu TM; Zuo T; Hsu PY; Lin CH; Cheng AL; Cui H; Yan PS; Huang TH
    Carcinogenesis; 2011 Jun; 32(6):812-21. PubMed ID: 21304052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.
    Tokunaga E; Okada S; Yamashita N; Akiyoshi S; Kitao H; Morita M; Kakeji Y; Maehara Y
    Breast Cancer; 2012 Apr; 19(2):161-9. PubMed ID: 21063923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women.
    Fabjani G; Tong D; Czerwenka K; Schuster E; Speiser P; Leodolter S; Zeillinger R
    Breast Cancer Res Treat; 2002 Mar; 72(2):131-7. PubMed ID: 12038703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer.
    Huiping C; Jonasson JG; Agnarsson BA; Sigbjornsdottir BI; Huebner K; Ingvarsson S
    Eur J Cancer; 2000 Aug; 36(12):1552-7. PubMed ID: 10930803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity in tumor tissue in hormonal receptor genes is associated with poor prognostic criteria in breast cancer.
    Iobagiu C; Lambert C; Raica M; Lima S; Khaddage A; Peoc'h M; Genin C
    Cancer Genet; 2015 Apr; 208(4):135-42. PubMed ID: 25979597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple mechanisms downregulate CDKN1C in human bladder cancer.
    Hoffmann MJ; Florl AR; Seifert HH; Schulz WA
    Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma.
    Lai S; Goepfert H; Gillenwater AM; Luna MA; El-Naggar AK
    Clin Cancer Res; 2000 Aug; 6(8):3172-6. PubMed ID: 10955800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer.
    Higashimoto K; Soejima H; Saito T; Okumura K; Mukai T
    Cytogenet Genome Res; 2006; 113(1-4):306-12. PubMed ID: 16575194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated CDKN1C/p57
    Qiu Z; Li Y; Zeng B; Guan X; Li H
    Biochem Biophys Res Commun; 2018 Feb; 497(1):187-193. PubMed ID: 29428729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.
    Ahomadegbe JC; Tourpin S; Kaghad M; Zelek L; Vayssade M; Mathieu MC; Rochard F; Spielmann M; Tursz T; Caput D; Riou G; Bénard J
    Oncogene; 2000 Nov; 19(47):5413-8. PubMed ID: 11103943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations in 'normal' luminal and myoepithelial cells of the breast.
    Lakhani SR; Chaggar R; Davies S; Jones C; Collins N; Odel C; Stratton MR; O'Hare MJ
    J Pathol; 1999 Dec; 189(4):496-503. PubMed ID: 10629549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues.
    Larson PS; Schlechter BL; de las Morenas A; Garber JE; Cupples LA; Rosenberg CL
    J Clin Oncol; 2005 Dec; 23(34):8613-9. PubMed ID: 16314623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDKN1C (p57KIP2) mRNA expression in human retinoblastomas.
    Madhavan J; Mallikarjuna K; Vikas K; George R; Bremner R; Kumaramanickavel G
    Ophthalmic Genet; 2010 Sep; 31(3):141-6. PubMed ID: 20565244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.
    Kouvaraki M; Gorgoulis VG; Rassidakis GZ; Liodis P; Koutroumbi E; Markopoulos C; Gogas J; Kittas C
    Anticancer Res; 2001; 21(2A):991-9. PubMed ID: 11396193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
    Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.
    Loo LW; Ton C; Wang YW; Grove DI; Bouzek H; Vartanian N; Lin MG; Yuan X; Lawton TL; Daling JR; Malone KE; Li CI; Hsu L; Porter PL
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1049-66. PubMed ID: 18720524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity in the RAD54B region is not predictive for breast carcinomas.
    Bryś M; Nowacka-Zawisza M; Romanowicz-Makowska H; Zadrozny M; Kulig A; Krajewska WM
    Pol J Pathol; 2007; 58(1):3-6. PubMed ID: 17585536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.